The Digital Health Podcast with Fexingo: Wearables, Diagnostics, and Health Software

Most digital health startups focus on the hardware — the watch, the ring, or the sensor. But a quiet crisis is unfolding in software: patient adherence. We examine why over seventy percent of users abandon their mental health apps within two weeks and how new behavioral economics models are changing that math. By looking at the specific mechanics of push notifications, habit loops, and clinical-grade software interventions, we explore whether the next trillion-dollar opportunity in healthcare lies not in detecting disease, but in keeping patients engaged enough to actually get better. This episode breaks down the retention metrics that matter and the companies quietly solving the engagement gap.

#DigitalHealth #BehavioralEconomics #PatientAdherence #HealthTech #MentalHealthApps #UserRetention #ClinicalSoftware #HabitFormation #FexingoBusiness #BusinessPodcast #HealthcareInnovation #StartupStrategy #EngagementMetrics #TherapeuticIntervention #ConsumerHealth #SaaSHealthcare #LucasAndLuna #HealthEconomics

Keep every episode free: buymeacoffee.com/fexingo

We explore how wearable data is reshaping health insurance models in September twenty twenty six. Using a specific case of a major insurer partnering with a leading smartwatch maker, we break down the mechanics of risk-adjusted pricing and what it means for consumers who opt in. Lucas and Luna discuss the trade-offs between lower premiums and privacy, the regulatory hurdles facing these programs, and whether this trend will become standard practice or remain a niche benefit. We look at the specific metrics insurers care about, from heart rate variability to step counts, and analyze the potential pitfalls of algorithmic bias in health underwriting.

#DigitalHealth #WearableTech #HealthInsurance #RiskAdjustment #Smartwatches #PrivacyPolicy #Insurtech #DataAnalytics #ConsumerHealth #AlgorithmicBias #PreventiveCare #FexingoBusiness #BusinessPodcast #TechTrends #FinanceNews #HealthData #Underwriting #SmartWatch

Keep every episode free: buymeacoffee.com/fexingo

In this episode, we explore the convergence of optometry and metabolic monitoring through smart contact lenses. Lucas and Luna examine how continuous glucose tracking is moving beyond wrist-worn devices into the eye itself. They discuss the engineering challenges of power delivery in a blink-sized device and the clinical implications for non-diabetic health optimization. The conversation anchors on recent pilot data showing correlation rates between tear fluid analysis and interstitial fluid glucose levels. Listeners will learn why the cornea is actually a better sensor window than the fingertip for real-time metabolic shifts, and what this means for the future of preventive healthcare technology.

#SmartContactLenses #ContinuousGlucoseMonitoring #DigitalHealthTech #WearableDiagnostics #HealthTechInnovation #MetabolicHealth #Biosensors #OcularTech #PreventiveMedicine #TearFluidAnalysis #Bioengineering #FutureOfHealthcare #MedicalDevices #FexingoBusiness #BusinessPodcast #TechTrends2026 #ConsumerHealth #BiomedicalEngineering

Keep every episode free: buymeacoffee.com/fexingo

We dig into the hidden economics of sleep tracking. With the market for digital sleep interventions growing rapidly, companies are shifting from selling hardware to selling data-driven subscriptions and B2B partnerships. Lucas and Luna explore how apps like Oura and Whoop are building moats around behavioral data, while new players like Eight Sleep focus on hardware integration. We examine the regulatory gray zone between wellness tools and medical devices, and why insurers are finally paying attention to sleep metrics as a cost-saving lever. This is the business side of your REM cycle.

#SleepTech #DigitalHealth #BusinessPodcast #FexingoBusiness #Wearables #HealthData #SubscriptionEconomy #BehavioralEconomics #OuraRing #WhoopBand #EightSleep #InsurerPartnerships #ConsumerHealth #SaaS #MedicalDevices #PreventiveCare #LucasAndLuna #MarketAnalysis

Keep every episode free: buymeacoffee.com/fexingo

Clinical trials have a diversity problem: Black and Hispanic patients are consistently underrepresented, and that skews drug safety and efficacy data. In this episode, Lucas and Luna look at how digital health tools are trying to fix it. They dig into the reasons behind the underrepresentation — from mistrust rooted in historical abuses to practical barriers like travel and time — and then explore concrete solutions: decentralized trials that let patients participate from home, wearable sensors that replace clinic visits, telehealth check-ins, and AI-driven recruitment that matches trials to patients more fairly. They also weigh the risks: could these tools end up widening the gap if they're not designed with equity in mind? With examples like a heart failure trial that cut site visits in half and a lung cancer screening program that used mobile vans to reach rural communities, this episode gives you a grounded look at a slow-moving but promising shift. If you've ever wondered why your medication might not work the same as your neighbor's, this one's for you.

#ClinicalTrials #HealthEquity #DigitalHealth #Wearables #DecentralizedTrials #AI #FDA #BlackHealth #HispanicHealth #DrugDevelopment #Telehealth #PatientRecruitment #Healthcare #Technology #Business #FexingoBusiness #BusinessPodcast #DigitalHealthPodcast

Keep every episode free: buymeacoffee.com/fexingo

Clinical trials are the bottleneck of modern medicine—slow, expensive, and often disconnected from real patients. In Episode 171 of The Digital Health Podcast, Lucas and Luna explore how artificial intelligence is quietly redesigning the trial process, from patient recruitment to real-time monitoring. They dig into the story of a mid-sized pharma company that cut its screening timeline from nine weeks to twelve days using an AI matching platform, and how decentralized trial software is keeping rural patients enrolled. They also unpack the ethical tightrope: can algorithms reduce bias, or do they just encode old inequalities? With 2026 seeing a record number of AI-assisted trials, the hosts ask what this means for the future of drug development—and for the patients waiting on the other side. No hype, just the data, the trade-offs, and one concrete takeaway you can mention to a friend.

#ClinicalTrials #ArtificialIntelligence #DigitalHealth #PatientRecruitment #DecentralizedTrials #PharmaTech #HealthTech #AIEthics #DrugDevelopment #RealWorldData #FexingoBusiness #BusinessPodcast #TechPodcast #HealthcareInnovation #TrialMatching #RuralHealth #BiasInAI #FutureOfMedicine

Keep every episode free: buymeacoffee.com/fexingo

In this episode of The Digital Health Podcast, Lucas and Luna explore how artificial intelligence is transforming medical imaging, from radiology to pathology. They dive into the story of an AI tool that detects breast cancer in mammograms with accuracy matching expert radiologists, and discuss the broader implications for healthcare: faster diagnoses, reduced costs, and the changing role of doctors. Along the way, they unpack the data behind these algorithms, the regulatory hurdles they face, and what it means for patients. If you've ever wondered whether AI will replace your radiologist—or just make them better—this episode offers a clear-eyed look at the technology that's quietly reshaping diagnostics.

#MedicalImagingAI #RadiologyAI #HealthTech #DigitalHealth #AIinHealthcare #DeepLearning #BreastCancerDetection #DiagnosticsAI #HealthcareInnovation #ArtificialIntelligence #MachineLearning #HealthSoftware #FDAApproval #PatientCare #BusinessAndTech #FexingoBusiness #BusinessPodcast #DigitalHealthPodcast

Keep every episode free: buymeacoffee.com/fexingo

Smart rings have gone from sleep-tracking novelty to serious medical devices. In this episode, Lucas and Luna break down how the latest generation of smart rings is earning FDA clearance and showing up in clinical trials. They dig into the specific sensors, battery tech, and data standards that made the shift possible, and why cardiologists are starting to prescribe them for remote monitoring of conditions like atrial fibrillation. With October 2026 seeing the first large-scale study published using ring data to detect irregular heart rhythms, the hosts explain why this tiny form factor might be the future of continuous patient monitoring. They also talk about the business side: who's winning the market, how reimbursement is shaping up, and what it means for the classic health-insurance model. If you've wondered whether your ring is just a gadget or a genuine medical tool, this episode gives you the clear-eyed answer.

#SmartRings #WearableTech #ClinicalGrade #RemotePatientMonitoring #AtrialFibrillation #DigitalHealth #HealthTech #MedicalDevices #FDA #ContinuousMonitoring #Cardiology #Wearables #HealthInnovation #Business #Technology #Podcast #FexingoBusiness #BusinessPodcast

Keep every episode free: buymeacoffee.com/fexingo

Smart rings are everywhere in 2026, from sleep tracking to cycle monitoring. But are they accurate enough for doctors to take seriously? In this episode, Lucas and Luna dig into the hardware constraints of a device that packs sensors into a tiny form factor, the regulatory shift that's pushing some rings toward FDA clearance, and why the clinical validation race is reshaping the entire wearable market. They break down the engineering trade-offs, the data gaps, and what a recent peer-reviewed comparison of ring versus smartwatch accuracy means for consumers and investors. If you're building in digital health or just deciding whether your ring's health score is worth trusting, this episode gives you the specifics you need. Fexingo Business Podcast Network.

#SmartRings #DigitalHealth #WearableTech #ClinicalValidation #FDA #HealthTech #Business #Technology #FexingoBusiness #BusinessPodcast #HealthcareInnovation #SleepTracking #HeartRateMonitoring #ConsumerWearables #MedicalDevices #HealthSensors #WearableAccuracy #RegulatoryAffairs

Keep every episode free: buymeacoffee.com/fexingo

Continuous glucose monitors were once the domain of people with diabetes. But by August 2026, a growing number of health-conscious consumers are wearing them to optimize energy, focus, and even athletic performance. In this episode, Lucas and Luna unpack the data behind this shift, from the falling cost of sensor technology to the rise of metabolic health programs at major employers. They explore a specific case: a mid-size tech company that offered CGMs to its entire workforce, and what the results revealed about productivity and healthcare costs. They also dig into the research on who actually benefits from wearing a CGM without diabetes, and where the evidence gets murky. Plus, they discuss the regulatory landscape, the role of startups versus established players, and why the biggest winners might be the companies selling the data, not the sensors. If you've ever wondered whether a CGM is worth the hype for someone without diabetes, this episode gives you the numbers to decide.

#ContinuousGlucoseMonitors #CGM #MetabolicHealth #Wearables #DigitalHealth #HealthTech #EmployeeWellness #PreventiveMedicine #Biomarkers #HealthData #Business #Technology #FexingoBusiness #BusinessPodcast #HealthPodcast #DigitalHealthPodcast #WearableTech #GlucoseMonitoring

Keep every episode free: buymeacoffee.com/fexingo